FABP2 and serum lipopolysaccharide activity: Indeed, in the context of mild systemic aggression, it was demonstrated that I-FABP could be dissociated from intestinal permeability in healthy patients with systemic inflammatory response syndrome (SIRS) induced by experimental endotoxemia, suggesting that gut barrier dysfunction may occur in the absence of enterocyte necrosis [40].